Table 2 Multivariate logistic regression analysis concerning having regret in the treatment decision-making process
All participants | BCS | TM | ||||
|---|---|---|---|---|---|---|
Characteristic | AOR | 95% CI | AOR | 95% CI | AOR | 95% CI |
Age | ||||||
< 50 years | 1 | (ref) | 1 | (ref) | 1 | (ref) |
≥ 50 years | 0.95 | (0.57–1.70) | 0.65 | (0.32–1.31) | 1.60 | (0.59–4.37) |
Age at diagnosis | ||||||
≤ 40 years | 1 | (ref) | 1 | (ref) | 1 | (ref) |
41–50 years | 0.61 | (0.33–1.10) | 0.91 | (0.42–1.98) | 0.19 | (0.06–0.61)** |
> 50 | 0.44 | (0.21–0.94)* | 0.54 | (0.20–1.45) | 0.19 | (0.04–0.87)* |
Marital status | ||||||
Married | 1 | (ref) | 1 | (ref) | 1 | (ref) |
Other | 1.53 | (0.96–2.44) | 1.54 | (0.86–2.74) | 1.81 | (0.77–4.23) |
Education | ||||||
≤ High school | 1 | (ref) | 1 | (ref) | 1 | (ref) |
> High school | 1.13 | (0.73–1.77) | 1.03 | (0.59–1.82) | 1.46 | (0.64–3.30) |
Household income | ||||||
< ¥5,000,000 | 1 | (ref) | 1 | (ref) | 1 | (ref) |
≥ ¥5,000,000 | 1.11 | (0.71–1.73) | 1.00 | (0.57–1.73) | 1.40 | (0.61–3.24) |
I do not know/ I do not want to share | 1.01 | (0.57–1.77) | 1.03 | (0.51–2.09) | 1.09 | (0.38–3.13) |
Employment status | ||||||
Full time | 1 | (ref) | 1 | (ref) | 1 | (ref) |
Contract/ part–time | 0.51 | (0.29–0.89)* | 0.41 | (0.20–0.82)* | 0.82 | (0.29–2.28) |
Others | 0.64 | (0.37–1.11) | 0.64 | (0.33–1.26) | 0.74 | (0.28–1.97) |
Time since diagnosis | ||||||
≤ 5 years | 1 | (ref) | 1 | (ref) | 1 | (ref) |
> 5 years | 1.07 | (0.69–1.67) | 1.09 | (0.63–1.90) | 1.16 | (0.49–2.74) |
Cancer stage | ||||||
0 | 1 | (ref) | 1 | (ref) | 1 | (ref) |
I | 0.94 | (0.52–1.70) | 0.95 | (0.45–2.01) | 0.79 | (0.26–2.42) |
II | 0.80 | (0.41–1.56) | 0.75 | (0.32–1.78) | 0.77 | (0.23–2.57) |
Surgery type | ||||||
Breast conserving surgery | 1 | (ref) | ||||
Total mastectomy | 2.10 | (1.11–3.98)* | ||||
Radiation therapy | ||||||
No | 1 | (ref) | 1 | (ref) | 1 | (ref) |
Yes | 1.69 | (0.90–3.17) | 1.61 | (0.70–3.69) | 1.99 | (0.68–5.87) |
Chemotherapy | ||||||
No | 1 | (ref) | 1 | (ref) | 1 | (ref) |
Yes | 1.26 | (0.79–2.01) | 1.25 | (0.70–2.24) | 1.48 | (0.63–3.45) |
Hormone | ||||||
No | 1 | (ref) | 1 | (ref) | 1 | (ref) |
Yes | 1.15 | (0.73–1.80) | 1.30 | (0.71–2.38) | 0.88 | (0.41–1.91) |
Preferred decision-making role | ||||||
Active | 1 | (ref) | 1 | (ref) | 1 | (ref) |
Collaborative | 1.04 | (0.65–1.68) | 0.77 | (0.42–1.40) | 1.65 | (0.67–4.06) |
Passive | 0.90 | (0.42–1.93) | 0.95 | (0.37–2.45) | 0.63 | (0.15–2.67) |
Perceived decision-making role | ||||||
Active | 1 | (ref) | 1 | (ref) | 1 | (ref) |
Collaborative | 0.54 | (0.32–0.90)* | 0.76 | (0.40–1.43) | 0.24 | (0.09–0.68)** |
Passive | 0.99 | 0.53–1.84 | 0.99 | (0.46–2.15) | 1.12 | (0.34–3.67) |
Decisional congruence | ||||||
Incongruence | 1 | (ref) | 1 | (ref) | 1 | (ref) |
Congruence | 0.70 | (0.45–1.10) | 0.56 | (0.32–0.98)* | 1.13 | (0.49–2.61) |